Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, Paolo Airó et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations · Full text

Public Health, Biostatistics, Cardiology +14

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

Jacob M. van Laar, Dominique Farge, Jacob K. Sont et al. · JAMA · 2014 · 744 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Mapping and predicting mortality from systemic sclerosis

Muriel Elhaï, Christophe Meune, Marouane Boubaya et al. · Annals of the Rheumatic Diseases · 2017 · 684 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein et al. · New England Journal of Medicine · 2018 · 589 citations · Full text

Medicine, Hematology, Immunology +13

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

Richard K. Burt, Sanjiv J. Shah, Karin E. Dill et al. · The Lancet · 2011 · 565 citations

Medicine, Hematology, Immunology +15